Donor-Derived CD5 CAR T Cells

CD5 CAR T cell therapy · Beijing Boren Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Donor-Derived CD5 CAR T Cells, covering 2024-11-14 to 2024-11-14. Get the full timeline:

Most recent: Clinical Trial Update: Donor-Derived CD5 CAR T Cells in Subjects with Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia [Phase 1]

See pricing